Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of controlled-release ropivacaine for postoperative incisional analgesia after laparoscopic surgery
ChiCTR2200065814Phase 2Not yet recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine in postoperative pain (4 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Cumulative use of rescue analgesics for incisional pain per kilogram body weight. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200065814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065814.